Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate
Author(s): Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
Issue: Jul/Aug 2011 - Volume 15, Number 4
View All Articles in Issue
Page(s): 344-349
Download in electronic PDF format for $75
Abstract: Sodium p-aminosalicylate is an orphan drug used in patients affected with multidrug-resistant tuberculosis. In this article, the preparation and characterization of a new alternative formulation of p-aminosalicylate is described. It consists of a powder for extemporaneous reconstitution, p-aminosaliyilate–extemporaneous, to be orally administered in solution. It is finally packaged in a tightly closed, light-resistant glass container as a unitary dose. In order to promote accessibility to multidrug-resistant tuberculosis treatment, the formulation is low cost and simple to manufacture, being compounded with only four ingredients. To improve patient compliance and treatment adherence, the unpleasant taste of p-aminosalicylate was masked as p-aminosalicylate–extemporaneous, which is easier to drink. The p-aminosalicylate–extemporaneous was characterized in relation to its content uniformity, time of blending, powder bulk properties (flowability), and stability. The proposed alternative formulation remained stable in its final containers for 3 months, as demonstrated by analytical assays and flowability properties.
Related Keywords:
sodium p-aminosalicylate, multidrug-resistant tuberculosis, formulation, drug resistance, patient compliance, extemporaneous reconstitution, bulk powder, stability, packaging, Argentina
Related Categories:
FORMULATIONS, PACKAGING, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate
Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
|
Jul/Aug 2011
Pg. 344-349
|
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation
Hergert Lisandro Y, Ravetti Soledad, Mazzieri Maria R
|
Jan/Feb 2016
Pg. 63-70
|
The Basics of Compounding Powders and Granules
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 36-39
|
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S, Thyangarajapuram N
|
Sep/Oct 2003
Pg. 389-393
|
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
|
May/Jun 2003
Pg. 233-239
|
Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
|
Jul/Aug 1999
Pg. 274-276
|
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Zhang Yanping, Trissel Lawrence A
|
May/Jun 2002
Pg. 226-229
|
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution
Alexander Kenneth S, Kaushik Sarita
|
Mar/Apr 2004
Pg. 147-152
|
Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
|
Jul/Aug 2003
Pg. 310-312
|
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Chauhan Nikita N, Patel Jayvadan K
|
Jan/Feb 2023
Pg. 60-71
|
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
|
Jan/Feb 2001
Pg. 9-12
|
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 71
|
Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
|
Nov/Dec 2021
Pg. 523-527
|
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs.
Xu Quanyun A, Trissel Lawrence A, Pham Lien
|
May/Jun 2004
Pg. 228-230
|
Formulation and Stability of Solutions
Akers Michael J
|
Mar/Apr 2016
Pg. 137-141
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion
Gupta Vishnu D
|
Mar/Apr 2004
Pg. 153-155
|
Book Reviews: Stability and Formulation References
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 25
|
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 38
|
Menthol Dusting Powder-Example of Powder Formulations
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 38
|
Return to Top |